Skip to content

Accuracy of Owlet Smart Sock Sensor 3rd Generation With Profound Hypoxia

Accuracy of Owlet Smart Sock Sensor 3rd Generation With Profound Hypoxia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04446247
Enrollment
14
Registered
2020-06-24
Start date
2020-03-12
Completion date
2020-03-13
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia

Keywords

Verification of SpO2 accuracy, Induced hypoxia, Owlet Smart Sock, Pulse oximeter

Brief summary

Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained. The blood sample is analyzed for oxygen saturation with a gold standard bench CO-oximeter. This protocol is aligned with the latest ISO and FDA guidance documents for pulse oximeter testing.

Interventions

DIAGNOSTIC_TESTOwlet Smart Sock Sensor 3rd Generation

Pulse Oximetry

Sponsors

Owlet Baby Care, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* The subject is male or female, aged ≥18 and \<50. * The subject is in good general health with no evidence of any medical problems. * The subject is fluent in both written and spoken English. * The subject has provided informed consent and is willing to comply with the study procedures.

Exclusion criteria

* The subject is obese (BMI\>30). * The subject has a known history of heart disease, lung disease, kidney or liver disease. * Diagnosis of asthma, sleep apnea, or use of CPAP. * Subject has diabetes. * Subject has a clotting disorder. * The subject a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation. * The subject has any other serious systemic illness. * The subject is a current smoker. * Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators' would interfere with the sensors working correctly. * The subject has a history of fainting or vasovagal response. * The subject has a history of sensitivity to local anesthesia. * The subject has a diagnosis of Raynaud's disease. * The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test). * The subject is pregnant, lactating or trying to get pregnant. * The subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures. * The subject has any other condition, which in the opinion of the investigators' would make them unsuitable for the study.

Design outcomes

Primary

MeasureTime frameDescription
SpO2 Accuracy (Arms) of ≤3 Between 70 and 100%1 hourDetermination of Average Root Mean Square SpO2 Accuracy of the Owlet Smart Sock 3rd Generation

Countries

United States

Participant flow

Participants by arm

ArmCount
ARMS SpO2 70-100%
Comparison to Reference CO-Oximetry Accuracy of the Owlet Smart Sock Sensor 3rd Generation: The purpose of this study was to validate the SpO2 accuracy of the Owlet Smart Sock Sensor 3rd Generation during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry. It was expected that the Accuracy Root Mean Square (ARMS) performance of the oximetry system would meet the required specification of ARMS of 3.0% or less.
14
ARMS SpO2 70-100%
Comparison to Reference CO-Oximetry Accuracy of the Owlet Smart Sock Sensor 3rd Generation: The purpose of this study was to validate the SpO2 accuracy of the Owlet Smart Sock Sensor 3rd Generation during non-motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry. It was expected that the Accuracy Root Mean Square (ARMS) performance of the oximetry system would meet the required specification of ARMS of 3.0% or less.
351
Total365

Baseline characteristics

CharacteristicARMS SpO2 70-100%
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
14 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
6 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
5 Participants
Region of Enrollment
United States
14 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
8 Participants
Skin Tone
Dark
1 Participants
Skin Tone
Dark-Medium
4 Participants
Skin Tone
Light
1 Participants
Skin Tone
Light- Medium
4 Participants
Skin Tone
Medium
4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 14
other
Total, other adverse events
0 / 140 / 14
serious
Total, serious adverse events
0 / 140 / 14

Outcome results

Primary

SpO2 Accuracy (Arms) of ≤3 Between 70 and 100%

Determination of Average Root Mean Square SpO2 Accuracy of the Owlet Smart Sock 3rd Generation

Time frame: 1 hour

ArmMeasureValue (NUMBER)
ARMS SpO2 70-100%, Oximeter #1 (Left)SpO2 Accuracy (Arms) of ≤3 Between 70 and 100%2.10 Percentage
ARMS SpO2 70-100%, Oximeter #2 (Right)SpO2 Accuracy (Arms) of ≤3 Between 70 and 100%2.19 Percentage

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026